METHODS OF TREATING TUMORS

The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase. La divulgation concerne des compo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZHAO, XIAOCHEN, HABY, THOMAS ARTHUR, KHOSSRAVI, MEHRNAZ, ROY, AMIT, MURTHY, BINDU PURNIMA, ARAS, URVI ASHISH, MANTRI, RAO VENKATRAMANA, VEZINA, HEATHER ELIZABETH, HUANG, MASANO, SANGHAVI, KINJAL, HART, SCOTT AARON, BELLO, AKINTUNDE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase. La divulgation concerne des compositions pharmaceutiques comprenant un anticorps anti-PD-1 ou un anticorps anti-PD-L1 formulé pour une administration sous-cutanée, les compositions pharmaceutiques comprenant en outre une enzyme endoglycosidase hydrolase telle qu'une hyaluronidase.